POST-ANESTHETIC REHABILITATION PERIODS AND ANESTHESIA DOSAGE FOR LAPAROSCOPIC CHOLECYSTECTOMY: RELATIONSHIP TO THE...

Area of Science:

• Anesthesiology
• Pharmacology
• Hepatology

Background:

• Anesthesia dosing requires individualization for optimal patient outcomes.
• Pharmacological phenotyping can assess liver function, impacting drug metabolism.
• Laparoscopic cholecystectomy is a common surgical procedure requiring general anesthesia.

Purpose of the Study:

• To evaluate the utility of the antipyrine test for individualizing trimeperidine (promedol) dosage.
• To determine if liver oxidative capacity and patient mass can guide anesthesia management.
• To assess the impact of tailored anesthesia on post-anesthetic rehabilitation periods.

Main Methods:

• Pharmacological phenotyping using the antipyrine test prior to anesthesia.
• Analysis of trimeperidine dosage adjusted for total oxidative capacity of the liver and patient mass.
• Assessment of post-anesthetic rehabilitation periods following laparoscopic cholecystectomy.

Main Results:

• Trimeperidine dosing, considering liver oxidative capacity and patient mass, can control post-anesthetic recovery.
• The antipyrine test is a simple, inexpensive, and informative method for individual anesthesia dosing.
• Further research is needed to develop a clear dosing algorithm due to limited sample size.

Conclusions:

• The antipyrine test is a valuable tool for optimizing general anesthesia adequacy.
• Individualized anesthesia dosing based on liver function improves patient recovery.
• The study supports the continued investigation and application of the antipyrine test in clinical anesthesia.